Company intelligence / Profile preview

SSY Group

Shijiazhuang, Hebei, Chinassygroup.com.hk ↗

Ownership: Private
Employees: ~6146
Development stage: Other

Overview

SSY Group Limited is one of the largest manufacturers of intravenous infusion solutions globally and a leading pharmaceutical company in China. The company has a strong commercial presence with advanced manufacturing capabilities and a broad product portfolio that includes small volume injections, oral preparations, Chinese medicine preparations, biological preparations, and peritoneal dialysis solutions. It recently received NMPA approval for passing consistency evaluation of its peritoneal dialysis solution.

Therapeutic areas: NephrologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

4 assets

SYN045

Unknown

3 more assets in the full pipeline.

Request access →

Partnerships

Sichuan Kelun Pharmaceutical Co., Ltd. (equity stake)

Beyond the preview

Go deeper on SSY Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSY Group.

Explore the full profile